SI-BONE, Inc.·4

Feb 18, 7:13 PM ET

Maheshwari Anshul 4

4 · SI-BONE, Inc. · Filed Feb 18, 2026

Research Summary

AI-generated summary of this filing

Updated

SI‑BONE (SIBN) CFO Anshul Maheshwari Receives Award, Sells Shares

What Happened

  • Anshul Maheshwari, Chief Financial Officer of SI‑BONE (SIBN), was granted a total of 107,992 restricted stock units (RSUs) on 2026-02-16 (three award entries: 80,994; 13,499; 13,499). On 2026-02-17 she sold 21,528 shares in multiple open‑market transactions, generating about $330,983 in proceeds. The sales were reported as sell‑to‑cover transactions to satisfy tax withholding obligations (not discretionary sales).

Key Details

  • Grant (award): 107,992 RSUs on 2026-02-16 (price $0.00) — these are contingent rights to receive one share per RSU.
  • Sales (open market) on 2026-02-17:
    • 1,279 shares @ $15.35 = $19,633
    • 11,104 shares @ $15.36 = $170,550
    • 2,189 shares @ $15.29 = $33,466
    • 3,065 shares @ $15.46 = $47,384
    • 3,891 shares @ $15.41 = $59,950
    • Total sold: 21,528 shares for ~$330,983. Several entries were executed in multiple trades; weighted average prices reported and trade price ranges per footnotes were roughly $15.13–$15.645.
  • Footnotes of note:
    • F1: One RSU grant vests quarterly over four years beginning Feb 15, 2026 (service‑based).
    • F2: One RSU grant vests over three years based on relative total shareholder return (performance‑based).
    • F3: The sales were "sell‑to‑cover" to satisfy tax withholding and are not discretionary trades.
    • F9: Filing references 200,237 shares issuable on settlement of RSUs (summary figure); the filing does not state a single total of all beneficially owned shares after these transactions.
  • Filing timing: Report filed 2026-02-18 for transactions on 2026-02-16 and 02-17; no late filing indication in this report.

Context

  • These transactions combine new RSU awards (a common form of executive compensation) and routine sell‑to‑cover transfers to satisfy taxes when RSUs vest or are issued. Awards are not an immediate cash purchase signal; the sales here were for tax withholding, per the filing. For retail investors, RSU grants increase potential future dilution over the vesting period; performance RSUs (F2) will only convert to shares if performance targets are met.

Insider Transaction Report

Form 4
Period: 2026-02-16
Maheshwari Anshul
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-16+80,994260,996 total
  • Award

    Common Stock

    [F2]
    2026-02-16+13,499274,495 total
  • Award

    Common Stock

    [F2]
    2026-02-16+13,499287,994 total
  • Sale

    Common Stock

    [F3][F4]
    2026-02-17$15.35/sh1,279$19,633286,715 total
  • Sale

    Common Stock

    [F3][F5]
    2026-02-17$15.36/sh11,104$170,550275,611 total
  • Sale

    Common Stock

    [F3][F6]
    2026-02-17$15.29/sh2,189$33,466273,422 total
  • Sale

    Common Stock

    [F3][F7]
    2026-02-17$15.46/sh3,065$47,384270,357 total
  • Sale

    Common Stock

    [F3][F8][F9]
    2026-02-17$15.41/sh3,891$59,950266,466 total
Footnotes (9)
  • [F1]Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest over four years beginning on February 15, 2026, and will be released in quarterly installments, subject to the Reporting Person's continued service through each relevant vesting date.
  • [F2]Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest, if at all, over three years based on the Issuer's total shareholder return (TSR) as measured against the TSR of the company at the median of the range TSRs of a set of peer companies established by the Issuer as set forth in the grant.
  • [F3]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
  • [F4]This transaction was executed in multiple trades at prices ranging from $15.18 USD to $15.54 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]This transaction was executed in multiple trades at prices ranging from $15.13 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]This transaction was executed in multiple trades at prices ranging from $15.14 USD to $15.52 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.645 USD; the price reported above reflects the weighted average sale price.
  • [F8]This transaction was executed in multiple trades at prices ranging from $15.24 USD to $15.62 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F9]Includes 200,237 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Signature
/s/ Michael Pisetsky, Attorney-in-Fact for Anshul Maheshwari|2026-02-18

Documents

2 files